Join NBTS’s campaign to raise awareness about the importance of biomarker testing and clinical trials for patients with brain tumors.
READ MOREBrain Tumor Community Pushes for Inclusion of Patient-Focused Endpoints In Future Clinical Trials Second Brain Tumor Clinical Trial Endpoints Workshop identified steps needed to include measures of patient signs, symptoms, and function as part of evaluation of therapy benefit November 6, 2014
National Brain Tumor Society 2014 Summit Reviews Systemic Change Happening in Brain Cancer Research & Development, Honors Community Leaders National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, hosted its 2014 Summit and Annual Meeting in Cambridge, MA, on October 1-2. The yearly event brought together a cross-section of the brain tumor community, including neuro-oncologists, medical academics, biotechnology and pharmaceutical executives, representatives from the National Institutes […] October 9, 2014
National Brain Tumor Society’s Advocates “Head to the Hill” to Speak Up for the Critical Needs of the Brain Tumor Community Brain tumor patients, survivors, and caregivers from across the country met with congressional leaders to discuss the issues facing the community May 6, 2014
National Brain Tumor Society Announces New Integrated Pediatric Research and Drug Development Initiative Project Impact aims to fundamentally change the way new pediatric cancer therapies are developed and tested, through public policy and a funded research program March 5, 2014
Neuro-Oncology Field Sets Action Plan to Advance Use of Imaging-Related Endpoints In Clinical Trials Seminal workshop hosts brain tumor patient advocates, leading neuro-oncologists, biopharmaceutical industry representatives, FDA, and NCI to advance strategies for establishing better pathways for therapy evaluation February 26, 2014